Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$388K Hold
3,200
– – ﹤0.01% 4377
2026
Q2
$363K Hold
3,200
– – ﹤0.01% 4328
2026
Q1
$301K Hold
3,200
– – ﹤0.01% 4069
2025
Q4
$316K Buy
+3,200
New +$310K ﹤0.01% 4123
2019
Q1
– Sell
-30,000
Closed -$1.91M – 3738
2018
Q4
$1.91M Hold
30,000
– – ﹤0.01% 2190
2018
Q3
$2.07M Hold
30,000
– – ﹤0.01% 2176
2018
Q2
$2.01M Hold
30,000
– – ﹤0.01% 2224
2018
Q1
$2.5M Sell
30,000
-40,000
-57% -$3.61M ﹤0.01% 1899
2017
Q4
$6.63M Buy
70,000
+40,000
+133% +$4.18M 0.01% 1298
2017
Q3
$3.5M Hold
30,000
– – 0.01% 1648
2017
Q2
$3.78M Hold
30,000
– – 0.01% 1544
2017
Q1
$4.01M Buy
+30,000
New +$3.82M 0.01% 1429
2016
Q1
– Sell
-30,000
Closed -$3.25M – 3586
2015
Q4
$3.25M Hold
30,000
– – ﹤0.01% 1756
2015
Q3
$3.31M Hold
30,000
– – ﹤0.01% 1708
2015
Q2
$3.13M Hold
30,000
– – ﹤0.01% 1836
2015
Q1
$2.75M Sell
30,000
-17,400
-37% -$1.44M ﹤0.01% 1790
2014
Q4
$3.46M Hold
47,400
– – ﹤0.01% 1836
2014
Q3
$2.32M Hold
47,400
– – ﹤0.01% 2127
2014
Q2
$2.68M Hold
47,400
– – ﹤0.01% 2079
2014
Q1
$2.54M Buy
47,400
+17,300
+57% +$1.07M ﹤0.01% 2151
2013
Q4
$1.52M Buy
30,100
+10,100
+51% +$439K ﹤0.01% 2776
2013
Q3
$763K Buy
+20,000
New +$590K ﹤0.01% 3284

Other funds holding INCY

David Shaw's INCY Position: Q3 2026 in Review

David Shaw sold out of Incyte (INCY) in Q3 2026, closing a stake of 4,016 shares — an estimated $490K sold.

David Shaw first reported a position in INCY in Q2 2013 and held it in 48 quarters. The position peaked at $188M in Q4 2021. 902 funds tracked by Wall St. Rank hold INCY as of Q3 2026.

  • David Shaw reported no remaining Incyte position as of Q3 2026 after selling out during the quarter.
  • David Shaw sold 4,016 Incyte shares in Q3 2026, an estimated $490K.
  • David Shaw first reported a position in Incyte in Q2 2013 and held it in 48 quarters.
  • David Shaw's Incyte position peaked at $188M in Q4 2021.
  • 902 funds tracked by Wall St. Rank held Incyte as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.